Purchase Order 75N98026P00452
Award Date 5/7/26
Potential Completion Date 9/30/26
Potential Value $16K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $29,645.10 firm fixed price purchase order to Biolegend, Inc. for BIOLEGEND REAGENTS. Biolegend, Inc. is a subsidiary of Revvity Inc. Medical Imaging, LLC. The place of performance will be Biolegend's facilities located in San Diego, California. The period of performance is from June 27, 2023 through September 30, 2023. No additional details were provided regarding subcontractors or the NIH...
- This federal contract award is for BIOLEGEND TOTALSEQ-C REAGENTS with a ceiling value of $48,965.00. The contract was awarded by the National Heart Lung and Blood Institute, a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and scientific research products located in San Diego, California. The contract is a firm fixed-price purchase order with an ultimate completion date of October 9, 2025. The...
- This $24,970 firm fixed price purchase order was awarded by the National Heart, Lung and Blood Institute of the National Institutes of Health to BioLegend, Inc., a medical division of Revvity Inc., to supply a custom human antibody panel. The solicitation requested TotalSeq-C Custom Human Panels consisting of 11 pouches with 5 reactions per pouch, for a total of 53 reactions. This antibody panel will support the Laboratory of Myeloid Malignancies' single-cell genomics and proteomics research...
- Biolegend, Inc. has been awarded a firm fixed price purchase order valued at ten thousand five hundred sixteen dollars and fifty cents ($10,516.50) by the Department of Health and Human Services' National Institutes of Health Clinical Center. The contract calls for Biolegend to supply antibodies for the Strich Laboratory's clinical trial investigating bacterial sepsis. No set-aside designation was used for this award. Biolegend will perform as the prime contractor, with all work taking place...
- This is a $14,856.75 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The award is for the provision of reagents and kits, with an ultimate completion date of May 28, 2025. Biolegend has previously served as a subcontractor to Parsons Government Services Inc. on...
- This is a $18,328.50 firm-fixed-price purchase order contract awarded to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies, by the National Institutes of Health (NIH) Clinical Center. The contract is for the provision of reagents and kits to support various research efforts across disease areas including COVID-19, multiple sclerosis, infectious diseases, allergies, immunology, oncology, and bone marrow disorders. Biolegend has a history of federal awards with the...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products for life science research and drug discovery. The $3,500.51 contract is to provide a variety of specialized reagents and products, such as oligonucleotide-tagged antibodies, TotalSeq antibody panels, and custom human antibody panels, to support research initiatives...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $24,998.40, is for the provision of TotalSeq B Human TBNK Cocktail products by the prime contractor, Biolegend, Inc. Biolegend is a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other scientific research products located in San Diego, California. The contract is for the procurement of biological and reagent materials, specifically Biolegend flow cytometer antibodies, with a ceiling value of $14,042.25...
- This federal contract award was made by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other scientific research products based in San Diego, California. The $10,492.50 firm-fixed-price purchase order is for the delivery of Total-Seq antibody cocktails, which are mixtures of antibodies conjugated to DNA oligonucleotides used in the preparation of...
The NIH Clinical Center awarded a purchase order to Biolegend, Inc. for $16,488.00 on May 7, 2026, for TOTALSEQ-D Human Heme Oncology Cocktail biomedical reagents. No small business set-aside was applied. Work is performed in San Diego, California. The order carries a firm fixed price and is scheduled for completion by September 30, 2026.
Generated 5/15/26, 9:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 5/7/26 |